Chemed Corp (CHE)

Chemed Corp is a common stock listed on the NYSE. The company operates through two business segments. Its VITAS unit provides hospice and palliative care services in the United States, supported by a multidisciplinary care network that can include physicians, nurses, home health aides, social workers, clergy, and volunteers. Through its Roto-Rooter segment, Chemed offers plumbing, drain cleaning, excavation, water restoration, and related services for residential and commercial customers, delivered through company-owned branches, independent contractors, and franchisees. Founded in 1970 and headquartered in Cincinnati, Ohio, Chemed combines healthcare services with service-related operations under one corporate structure.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-CHE
$576.11
13.6% Upside
Fair
$552
8.9% Upside
Fair
Good
0.5%
November 3, 2026
24.1x
8.0x
2.6x
6.637 B
6.891 B
4.3%
91.0%
15.3
12.1%
117.7%
Valuation • Fair Value

Chemed Corp (NYSE-CHE) Fair Value by Valuation Model

Review the available estimates for Chemed Corp (NYSE-CHE), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$576.11

Estimated upside of 13.6% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$604.54

Discounted cash flow valuation reference.

Ben Graham Formula Value

$234.44

Classic Ben Graham valuation formula reference.

DDM Fair Value

$661.81

Dividend discount model valuation reference.

EPV Fair Value

$321.59

Earnings power value estimate.

Comps Fair Value

$561.52

Comparable-company valuation reference.

Analyst Price Target

$552

Analysts imply upside of 8.9%.

How to read these valuation models

Use the 8 available valuation references for Chemed Corp (NYSE-CHE) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Chemed Corp (NYSE-CHE)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

2.595 B

Current operating scale indicator.

Revenue Forecast

2.721 B

Forward revenue estimate.

EBITDA

416.9 M

Current operating profitability reference.

EBITDA Forecast

516.4 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Chemed Corp (NYSE-CHE) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Chemed Corp (NYSE-CHE)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.95

No elevated caution signal from this screen.

Altman Z-Score

15.3

Relatively strong balance-sheet zone.

FCF / Net Income

117.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Chemed Corp (NYSE-CHE). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Chemed Corp (NYSE-CHE)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 3, 2026

Days to Earnings

47

Dividend Yield

0.5%

Current income yield reference.

Payout Ratio

12.1%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Chemed Corp (NYSE-CHE), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Chemed Corp (NYSE-CHE) Stock Forecast & Technical Outlook

Review Chemed Corp (NYSE-CHE) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Chemed Corp (NYSE-CHE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Chemed Corp (NYSE-CHE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Chemed Corp (NYSE-CHE) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Chemed Corp (NYSE-CHE) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Chemed Corp (NYSE-CHE) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Chemed Corp (NYSE-CHE)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Chemed Corp (NYSE-CHE) has a Hold consensus, with 1 buy, 3 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 3
Sell 0
FAQ Fast Investor Answers

Chemed Corp (NYSE-CHE) Stock FAQ

Data-supported answers about Chemed Corp (NYSE-CHE), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$576.11
Estimated upside 13.6%
Valuation Rating
Undervalued
Estimated upside of 13.6%
Analyst Target
$552
Implied upside 8.9%
Financial Health
Good
Current financial-health read

The current fair value estimate for Chemed Corp (NYSE-CHE) is $576.11. This implies an estimated upside of 13.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 13.6% versus the current market price.

The available analyst price target for Chemed Corp (NYSE-CHE) is $552. The analyst target implies estimated upside of 8.9%.

The current financial health read for Chemed Corp (NYSE-CHE) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Chemed Corp (NYSE-CHE) is November 3, 2026.

Based on the current data, dividend yield is 0.5%.

The current P/E ratio listed for Chemed Corp (NYSE-CHE) is 24.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Chemed Corp is 6.637 B.

The current enterprise value listed for Chemed Corp is 6.891 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Chemed Corp is NYSE-CHE, and the stock is listed on NYSE.

Chemed Corp (NYSE-CHE) is listed on NYSE.

The current debt-to-total-capital ratio listed for Chemed Corp is 4.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Chemed Corp is 91.0%. Free float helps investors understand how much of the share base is available for public trading.